Generating up to 100 times more antiviral drug candidates than was previously practical — in weeks rather than months or years — could improve the odds of finding a drug quickly when necessary.
Articles on Pharmaceuticals
Displaying 1 - 20 of 262 articles
It sounds gross. Drugs seeping out of your body may be damaging your leather sofa. But how worried should we be, really?
It’s hard to know exactly how big an issue this is today, whether this is becoming more common or how much it costs taxpayers. But here’s what we know so far.
When parents stop a medication they need or interrupt breastfeeding earlier than intended, the impact affects both mother and child. We need better evidence and decision support.
History has shown that when manufacturers skimp on sterile filtration of drugs, the consequences can amount to the loss of hundreds of lives and millions of dollars.
International drug companies are threatening to remove medicines from the market if Australia doesn’t offer them a better price. Here’s what’s at stake.
From October 1, specially qualified nurses will be able to prescribe medications and renew scripts at the subsidised price.
This drug is used to treat endometriosis and some breast cancers, but will soon be stripped from Australian shelves.
Don’t cut your patches in half, as this stops them working. There’s no need to ration your supplies – here are other options to ease your menopause symptoms.
Business is booming for fakes, worth at least US$467 billion a year worldwide. But some fake products can pose serious health risks to unsuspecting buyers.
Better information, smarter prescribing and investment in domestic manufacturing could help the NHS weather the growing crisis of medicines running short.
It may seem tempting to try to match the UK’s zero-tariff deal. But here’s why it’s not worth compromising on what Australians pay for essential medicines.
We asked 5 experts if clinics should be allowed to prescribe medicinal cannabis if they have financial links to the supplier or dispenser. Here’s what they said.
Nigeria’s reliance on imported medicines is the outcome of a policy vacuum that has entrenched interests in commercially attractive, low-risk imports.
Medicine is steadily improving its evidence base, but in children, careful research and ethical limits mean progress takes time.
Among a range of proposed reforms, Australia’s therapeutic goods regulator outlines 3 options for SPF labelling – including removing the numbers altogether.
Several years worth of findings from a floating laboratory have tapped into a well-stocked coral library of taxonomic, genetic and chemical diversity, previously unknown to Science and Medicine.
Before Canada decides to rely on foreign drug regulators to approve new medicines, Health Canada needs to show that it will improve public health.
The proposed rescheduling of marijuana could have far-reaching implications in science, medicine and criminal justice. What is the best policy option?
Two major trials show the weight-loss drug offers no cognitive benefit to people with early Alzheimer’s, dashing hopes it might protect the brain.
Top contributors
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Director and Taylor Family Chair, Centre for the Business & Economics of Health, The University of Queensland
-
Lecturer Pharmacy Practice, University of Sydney
-
Conjoint Clinical Associate Professor, Deakin University School of Medicine and Specialist Pain Medicine Physician, Deakin University
-
Pharmacist and PhD Candidate, University of Sydney
-
Professor of Bioethics, Macquarie University
-
Assistant Professor of Resource Economics, UMass Amherst
-
Professor of Trade Law and Taxation, Queensland University of Technology
-
Senior Research Manager, University of Sydney and Honorary Assistant Professor, Bond University
-
PhD Candidate, Swinburne University of Technology
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Senior Lecturer, Pharmacy, Aston University
-
Professor of Economics, Loughborough University